Blog

. In the current scenario, pharmaceutical companies will need to anticipate that value-generating information and insights will be available to their teams within analytics systems and not only be a source of reporting.

98.6 per cent of managers aspire to a data-based culture in their organizations, but only 32.4 per cent indicate that they are successful in this regard. In this age of digital disruption, new opportunities are opened that allow us to anticipate business challenges and create a competitive advantage.

Leveraging cloud technologies, a modern data architecture enables a cost effective, scalable data platform to be delivered quickly. This blog explores the components of the architecture that SDG Group deploys on a regular basis.

In the new horizon of 2021, with pressure accelerated by innovation, process optimization and production, and in the context of increasingly demanding regulations, digital transformation in the pharmaceutical industry is changing the paradigm we know.

A data strategy is a crucial contributor to business success but when is the best time to have one and on what should it focus?

This blog explores the key aspects of a data strategy and highlights some important considerations.

SDG Group has focused its work on the opportunities offered by the application of Artificial Intelligence in telemedicine: under the supervision of the Global CEO Luca Quagini, it has dedicated its best resources for the development of two solutions that guarantee different applications in many contexts.